138 related articles for article (PubMed ID: 19665595)
1. Structural organization of WrbA in apo- and holoprotein crystals.
Wolfova J; Smatanova IK; Brynda J; Mesters JR; Lapkouski M; Kuty M; Natalello A; Chatterjee N; Chern SY; Ebbel E; Ricci A; Grandori R; Ettrich R; Carey J
Biochim Biophys Acta; 2009 Sep; 1794(9):1288-98. PubMed ID: 19665595
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics comparison of E. coli WrbA apoprotein and holoprotein.
Reha D; Harish B; Sinha D; Kukacka Z; McSally J; Ettrichova O; Novak P; Carey J; Ettrich R
J Mol Model; 2014 Sep; 20(9):2400. PubMed ID: 25152065
[TBL] [Abstract][Full Text] [Related]
3. Role of flavin mononucleotide in the thermostability and oligomerization of Escherichia coli stress-defense protein WrbA.
Natalello A; Doglia SM; Carey J; Grandori R
Biochemistry; 2007 Jan; 46(2):543-53. PubMed ID: 17209564
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary diffraction analysis of Escherichia coli WrbA in complex with its cofactor flavin mononucleotide.
Wolfová J; Mesters JR; Brynda J; Grandori R; Natalello A; Carey J; Kutá Smatanová I
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Jul; 63(Pt 7):571-5. PubMed ID: 17620713
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the tryptophan repressor binding protein WrbA and complexes with flavin mononucleotide.
Gorman J; Shapiro L
Protein Sci; 2005 Dec; 14(12):3004-12. PubMed ID: 16322580
[TBL] [Abstract][Full Text] [Related]
6. 1.2 Å resolution crystal structure of Escherichia coli WrbA holoprotein.
Kishko I; Carey J; Reha D; Brynda J; Winkler R; Harish B; Guerra R; Ettrichova O; Kukacka Z; Sheryemyetyeva O; Novak P; Kuty M; Kuta Smatanova I; Ettrich R; Lapkouski M
Acta Crystallogr D Biol Crystallogr; 2013 Sep; 69(Pt 9):1748-57. PubMed ID: 23999298
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of WrbA, founding member of a new family of multimeric flavodoxin-like proteins.
Grandori R; Khalifah P; Boice JA; Fairman R; Giovanielli K; Carey J
J Biol Chem; 1998 Aug; 273(33):20960-6. PubMed ID: 9694845
[TBL] [Abstract][Full Text] [Related]
8. Conformational dynamics of Escherichia coli flavodoxins in apo- and holo-states by solution NMR spectroscopy.
Ye Q; Hu Y; Jin C
PLoS One; 2014; 9(8):e103936. PubMed ID: 25093851
[TBL] [Abstract][Full Text] [Related]
9. WrbA bridges bacterial flavodoxins and eukaryotic NAD(P)H:quinone oxidoreductases.
Carey J; Brynda J; Wolfová J; Grandori R; Gustavsson T; Ettrich R; Smatanová IK
Protein Sci; 2007 Oct; 16(10):2301-5. PubMed ID: 17893367
[TBL] [Abstract][Full Text] [Related]
10. Six new candidate members of the alpha/beta twisted open-sheet family detected by sequence similarity to flavodoxin.
Grandori R; Carey J
Protein Sci; 1994 Dec; 3(12):2185-93. PubMed ID: 7756978
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of Escherichia coli SsuE: defining a general catalytic cycle for FMN reductases of the flavodoxin-like superfamily.
Driggers CM; Dayal PV; Ellis HR; Karplus PA
Biochemistry; 2014 Jun; 53(21):3509-19. PubMed ID: 24816272
[TBL] [Abstract][Full Text] [Related]
12. Common conformational changes in flavodoxins induced by FMN and anion binding: the structure of Helicobacter pylori apoflavodoxin.
Martínez-Júlvez M; Cremades N; Bueno M; Pérez-Dorado I; Maya C; Cuesta-López S; Prada D; Falo F; Hermoso JA; Sancho J
Proteins; 2007 Nov; 69(3):581-94. PubMed ID: 17623845
[TBL] [Abstract][Full Text] [Related]
13. How FMN binds to anabaena apoflavodoxin: a hydrophobic encounter at an open binding site.
Lostao A; Daoudi F; Irún MP; Ramon A; Fernández-Cabrera C; Romero A; Sancho J
J Biol Chem; 2003 Jun; 278(26):24053-61. PubMed ID: 12682068
[TBL] [Abstract][Full Text] [Related]
14. Streptococcus pneumoniae TIGR4 Flavodoxin: Structural and Biophysical Characterization of a Novel Drug Target.
Rodríguez-Cárdenas Á; Rojas AL; Conde-Giménez M; Velázquez-Campoy A; Hurtado-Guerrero R; Sancho J
PLoS One; 2016; 11(9):e0161020. PubMed ID: 27649488
[TBL] [Abstract][Full Text] [Related]
15. The midpoint potentials for the oxidized-semiquinone couple for Gly57 mutants of the Clostridium beijerinckii flavodoxin correlate with changes in the hydrogen-bonding interaction with the proton on N(5) of the reduced flavin mononucleotide cofactor as measured by NMR chemical shift temperature dependencies.
Chang FC; Swenson RP
Biochemistry; 1999 Jun; 38(22):7168-76. PubMed ID: 10353827
[TBL] [Abstract][Full Text] [Related]
16. Apoflavodoxin: structure, stability, and FMN binding.
Maldonado S; Lostao A; Irún MP; Férnandez-Recio J; Gustavo Genzor C; Begoña González E; Rubio JA; Luquita A; Daoudi F; Sancho J
Biochimie; 1998 Oct; 80(10):813-20. PubMed ID: 9893940
[TBL] [Abstract][Full Text] [Related]
17. Thermal unfolding of Apo and Holo Desulfovibrio desulfuricans flavodoxin: cofactor stabilizes folded and intermediate states.
Muralidhara BK; Wittung-Stafshede P
Biochemistry; 2004 Oct; 43(40):12855-64. PubMed ID: 15461458
[TBL] [Abstract][Full Text] [Related]
18. Differential stabilization of the three FMN redox forms by tyrosine 94 and tryptophan 57 in flavodoxin from Anabaena and its influence on the redox potentials.
Lostao A; Gómez-Moreno C; Mayhew SG; Sancho J
Biochemistry; 1997 Nov; 36(47):14334-44. PubMed ID: 9398151
[TBL] [Abstract][Full Text] [Related]
19. Native-specific stabilization of flavodoxin by the FMN cofactor: structural and thermodynamical explanation.
Campos LA; Sancho J
Proteins; 2006 May; 63(3):581-94. PubMed ID: 16444751
[TBL] [Abstract][Full Text] [Related]
20. X-ray crystal structure of the Desulfovibrio vulgaris (Hildenborough) apoflavodoxin-riboflavin complex.
Walsh MA; McCarthy A; O'Farrell PA; McArdle P; Cunningham PD; Mayhew SG; Higgins TM
Eur J Biochem; 1998 Dec; 258(2):362-71. PubMed ID: 9874201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
